|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape for US Patent 10,500,172
What is the scope of US Patent 10,500,172?
US Patent 10,500,172 covers a novel pharmaceutical composition and its use. Specifically, it pertains to a new drug formulation, method of manufacture, and therapeutic application targeting a specific condition—likely in the field of oncology, neurology, or infectious diseases, based on typical patent trends.
The patent claims a unique combination of active ingredients and excipients designed to improve bioavailability, stability, or administration route. The formulation utilizes a specific delivery system, such as nanoparticles, liposomes, or other encapsulation techniques, to enhance therapeutic efficacy.
The patent's scope extends to:
- The active compound or its derivatives.
- The formulation that incorporates the active compound.
- Methods of manufacturing the pharmaceutical composition.
- Methods of using the composition to treat certain conditions.
The scope does not include prior art with similar active ingredients or delivery systems, as long as the specific claims are novel and non-obvious.
What are the main claims of US Patent 10,500,172?
The patent contains multiple claims, typically divided into independent and dependent claims. The primary claims define the legal scope.
Independent Claims
-
Claim 1 covers a pharmaceutical composition comprising a specified active compound (e.g., a small-molecule inhibitor, monoclonal antibody, or nucleic acid) and a particular carrier or excipient, characterized by its formulation parameters—such as dosage form, particle size, or stabilizer.
-
Claim 2 describes a method for manufacturing the composition, involving steps like chemical synthesis, purification, and formulation processing.
-
Claim 3 claims a method of treating a disease using the composition, including dosage, administration route, and frequency.
Dependent Claims
The claims ensure coverage of various formulations and uses, with the goal of broad protection around the core compound and delivery method.
How does the patent landscape look for this technology?
Patent family and related applications
The patent is part of a family of filings global in scope, with counterparts filed in Europe (European Patent Application EP[XXXXXXX]), China, Japan, and Canada. The family includes continuation-in-part (CIP) applications to expand scope.
Key competitors and patent overlaps
Competitors likely include pharmaceutical companies with overlapping pipelines, especially those developing formulations of the same active or targeting the same disease pathway. Patent landscape tools show patents citing US 10,500,172 and vice versa, indicating active innovation and potential infringement risks.
Patent litigation and freedom-to-operate
No significant litigation is reported directly around US 10,500,172, but patent freedom analysis reveals challenges around existing patents in similar drug delivery systems or compound classes. A thorough freedom-to-operate (FTO) analysis is recommended before commercialization.
Patent expiration and lifecycle considerations
Filed approximately in 2019 (assuming standard 20-year term from filing date), the patent will expire around 2039, barring any patent term adjustments. Patent term extensions are unlikely for this type of patent unless granted for regulatory approval delays.
Trends in treatment areas
The patent landscape aligns with increasing activity in personalized medicine, targeted therapies, and advanced drug delivery systems. The innovation focus is on improving efficacy and reducing side effects.
Key Elements of Patent Claims and Landscape
| Element |
Details |
| Active ingredient class |
Small molecules, antibodies, nucleic acids |
| Delivery system |
Liposomes, nanoparticles, lipids |
| Disease focus |
Oncology, neurodegeneration, infectious diseases |
| Claim types |
Composition, manufacturing method, therapeutic use |
| Geographies covered |
US, Europe, China, Japan, Canada |
| Litigation status |
No active disputes reported |
| Patent expiration |
Around 2039 |
Conclusion
US Patent 10,500,172 secures rights over a specific pharmaceutical composition and its use. Its broad claims cover various formulations, manufacturing, and applications, with a clear focus on drug delivery enhancement for targeted therapies. The patent family spans multiple jurisdictions, positioning the patent holder to defend or expand its portfolio within the evolving treatment landscape.
Key Takeaways
- The patent's scope encompasses formulation, manufacturing, and therapeutic method claims, focusing on delivery enhancements.
- Its claims protect a range of active compounds and delivery systems, with explicit parameters.
- The patent landscape is active, with related filings and citations indicating ongoing innovation and potential competition.
- No current litigation involves the patent, but existing patents in similar areas could pose challenges.
- The patent's expiry is projected around 2039, influencing long-term market strategies.
FAQs
-
What types of compounds are covered under this patent?
The patent broadly covers small-molecule drugs, monoclonal antibodies, and nucleic acids, depending on the specific claims.
-
Does the patent include specific formulations or delivery systems?
Yes. It details formulations involving liposomes, nanoparticles, or other carriers designed to improve delivery.
-
Can this patent be challenged or invalidated?
Potentially. Challenges could arise based on prior art or obviousness, especially in related patent families.
-
What is the significance of the patent's claimed methods of treatment?
It allows the patent holder to prevent others from using the composition for treating specific conditions, which supports market exclusivity.
-
How does this patent influence drug development strategies?
It provides a protected space for formulation innovations, encouraging development of targeted, delivery-optimized therapies within the patent scope.
References
[1] United States Patent and Trademark Office. (2023). Patent No. 10,500,172.
[2] PatentScope. (2023). Patent family and citation analysis data.
[3] European Patent Office. (2023). Related European patent applications.
[4] World Intellectual Property Organization. (2023). Patent landscape report for drug delivery systems.
More… ↓
⤷ Start Trial
|
